Lack of Influence of TP53 Arg72Pro and 16bp Duplication Polymorphisms on Risk of Breast Cancer in Iran |
Gohari-Lasaki, Sahar
(Department of Medical Genetics, School of Medicine, Hematology and Oncology Research Center, Tabriz University of Medical Sciences)
Gharesouran, Jalal (Department of Medical Genetics, School of Medicine, Hematology and Oncology Research Center, Tabriz University of Medical Sciences) Ghojazadeh, Morteza (Department of RDCC, School of Medicine, Hematology and Oncology Research Center, Tabriz University of Medical Sciences) Montazeri, Vahid (Department of General Surgery, School of Medicine, Hematology and Oncology Research Center, Tabriz University of Medical Sciences) Ardebili, Seiied Moitaba Mohaddes (Department of Medical Genetics, School of Medicine, Hematology and Oncology Research Center, Tabriz University of Medical Sciences) |
1 | Ainsley W and James H (1997). Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer:a meta-analysis. Environ Health Perspect, 4, 919-26. |
2 | Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, et al (2011). P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol, 28, 709-15. DOI ScienceOn |
3 | Bellini MF, Cadamuro AC, Succi M, Proenca MA, et al (2012). Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomedicine Biotechnol, 2012, 89196. |
4 | Bergamaschi D, GascoM, Hiller L, et al (2003). p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell, 3, 387-402. DOI |
5 | Berrada N, Amzazi S, Ameziane-El-Hassani R, et al (2013). No evidence of correlation between p53 codon 72 polymorphism and risk of bladder cancer in Moroccan patients. Clin Cancer Invest J, 1, 302-6. |
6 | Costa S, Pinto D, Pereira D, et al (2008). Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC cancer. 8, 32. DOI |
7 | Guleria K, Sharma S, Manjari M, et al (2012). p.R72P, PIN3 Ins16bp polymorphisms of tp53 and ccr5?32 in north indian breast cancer patients. Asian Pac J Cancer Prev, 13, 3305-11. DOI ScienceOn |
8 | Hrstka R, Beranek M, Klocova K, et al(2009).Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer. Oncol Reports, 22, 1205-11 |
9 | Hu Z, Li X, Yuan R, et al (2010). Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat, 120, 705-14. DOI |
10 | Oliveira A, Ross J, Fletcher J (2005). Tumor suppressor genes in breast cancer, Am J Clin Pathol, 124, 16-28. |
11 | Papadakis EN, Dokianakis DN, Spandidos DA (2000). p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Communicat, 3, 389-92. DOI ScienceOn |
12 | Samson M, Swaminathan R, Rama R, et al (2007). Role of GSTM1 (null/present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer - a case control study from South India. Asian Pac J Cancer Prev, 8, 253-7. |
13 | Sharma S, Sambyal V, Guleria K, et al (2014). TP53 polymorphisms in sporadic north indian breast cancer patients. Asian Pac J Cancer Prev, 15, 6871-9. DOI |
14 | Siddique M, Balram C, Fiszer-Maliszewska L, et al (2005). Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development. Cancer Epidemiol Biomarkers Prev, 14, 2245-52. DOI |
15 | Whibley C, Pharoah PD, Hollstein M (2009). p53 polymorphisms: cancer Implications. Nat Rev Cancer, 9,95-10. DOI ScienceOn |
16 | Sjalander A, Birgander R, Hallmans G, et al (1996). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-6. DOI |
17 | Vijayaraman K, Veluchamy M, Murugesan P, et al (2012). p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu. Asian Pac J Cancer Prev, 13, 511-6. DOI ScienceOn |
18 | Wang-Gohrke S, Rebbeck TR, Besenfelder W, et al (1998). p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res, 18, 2095-9. |
19 | Zhou X, Gu Y, Zhang S (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a huge review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. DOI ScienceOn |